Cencora, Inc. (NYSE:COR) Announces Quarterly Dividend of $0.60

Cencora, Inc. (NYSE:COR) declared a quarterly dividend on Wednesday, February 4th. Investors of record on Friday, February 13th will be paid a dividend of 0.60 per share on Monday, March 2nd. This represents a c) annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 13th.

Cencora has raised its dividend by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 15 years. Cencora has a dividend payout ratio of 13.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Cencora to earn $16.88 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 14.2%.

Cencora Stock Down 8.8%

Cencora stock traded down $31.88 during midday trading on Wednesday, reaching $329.87. The company’s stock had a trading volume of 3,226,170 shares, compared to its average volume of 1,242,188. The company has a debt-to-equity ratio of 4.32, a current ratio of 0.90 and a quick ratio of 0.55. The stock has a market capitalization of $63.99 billion, a P/E ratio of 41.49, a PEG ratio of 1.73 and a beta of 0.68. The stock’s 50-day simple moving average is $347.21 and its 200-day simple moving average is $325.24. Cencora has a 52-week low of $237.71 and a 52-week high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a net margin of 0.48% and a return on equity of 227.15%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.73 earnings per share. On average, sell-side analysts expect that Cencora will post 15.37 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Robert W. Baird set a $415.00 price target on shares of Cencora in a research note on Tuesday, January 13th. UBS Group boosted their price objective on shares of Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a report on Friday, November 7th. Mizuho raised their target price on Cencora from $340.00 to $380.00 and gave the stock an “outperform” rating in a research note on Thursday, November 6th. Wall Street Zen cut Cencora from a “buy” rating to a “hold” rating in a research report on Friday, November 28th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Cencora in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Cencora has an average rating of “Moderate Buy” and a consensus price target of $393.08.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.